FET PET for evaluating brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known or suspected brain tumor.
- You have either finished treatment (radiation or surgery) and an MRI suggests the tumor could be returning, OR you have not yet started treatment and are scheduled for a biopsy or surgery.
- You are 4 years old or older.
- You do not have any condition that would make PET, CT, or MRI scans unsafe or impossible for you.
- You are willing and able to follow the study procedures (sedation can be used if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at brain tumors (both new and returning) to help doctors understand them better and see how well treatment is working.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This study tests a special imaging method to look at brain tumors before surgery. It uses a tracer that may help doctors see tumors more clearly.
This study uses a special PET scan to help doctors tell the difference between side effects of radiation (pseudoprogression) and actual tumor growth in people with glioblastoma. It aims to avoid unnecessary treatments and guide the next steps in your care.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
Hear when a new Intracranial Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.